AstraZeneca has opened its first U.S.-operated cell therapy manufacturing plant in Rockville, Maryland, as part of its ...

The investment strengthens Maryland’s position as a biotech hub and reflects AstraZeneca’s commitment to local job creation ...

The facility, which will produce cell therapies used to treat cancer and auto immune diseases, creates 150 jobs for highly ...

As it applies to the development of cell therapies, AstraZeneca’s chief of global operations, Pam Cheng, admits that the ...

Larry Hogan speaks to members of the media at the AstraZeneca facility in Gaithersburg, Md., on Aug. 26, 2024. Larry Hogan ...

Cell therapy is considered by some as the next frontier in cancer treatment, engineering patients' own immune systems to ...

The facility to manufacture cell therapies for cancer research is part of the company's push to invest $3.5B in its U.S. operations by the end of 2026.

Local leaders and state officials are trying to help federal workers find stability and chart a new path forward in Maryland.

AstraZeneca has axed three MedImmune legacy monoclonal antibody drugs from its neuroscience pipeline in a first-quarter clear ...

AstraZeneca opens a $300M CAR-T cell therapy facility in Rockville, boosting Maryland's life sciences sector and creating ...

AstraZeneca, as part of its ongoing $3.5 billion investment in American innovation, opened its first U.S.-operated cell therapy factory in Maryland to help treat cancer patients. The U.K-based ...